Skip to main content
SpringerLink
Log in

The “pharmacophore rule” and the “spices”

  • Letter to the Editor
  • Published:
Forensic Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Huffman JW, Dai D, Martin BR, Compton DR (1994) Design, synthesis and pharmacology of cannabimimetic indoles. Bioorg Med Chem 4:563–566

    Article  Google Scholar 

  2. Seely KA, Lapoint J, Moran JH, Fattore L (2012) Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry 39:234–243

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. The United States Congress (2011) Schedules of controlled substances: temporary placement of five synthetic cannabinoids into Schedule I. 76 Federal Register 40 (01 March 2011) pp 11075-11078

  4. Huffman JW, Padgett LW (2005) Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr Med Chem 12:1395–1411

    Article  CAS  PubMed  Google Scholar 

  5. Aung MM, Griffin G, Huffman JW, Wu M-J, Keel C, Yang B, Showalter VM, Abood ME, Martin BR (2000) Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Dep 60:133–140

    Article  CAS  Google Scholar 

  6. Jordon AM, Roughley SD (2009) Drug discovery chemistry: a primer for the non-specialist. Drug Discov Today 14:731–744

    Article  Google Scholar 

  7. Gaoni Y, Mechoulam R (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86:1646–1947

    Article  CAS  Google Scholar 

  8. Devane WA, Dysarz FA 3rd, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613

    CAS  PubMed  Google Scholar 

  9. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561–564

    Article  CAS  PubMed  Google Scholar 

  10. Nestler EJ (2005) Is there a common molecular pathway for addiction? Nature Neurosci 8:1445–1449

    Article  CAS  PubMed  Google Scholar 

  11. Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of a mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276:2048–2050

    Article  CAS  PubMed  Google Scholar 

  12. Gessa GL, Melis M, Muntoni AL, Diana M (1998) Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 341:39–44

    Article  CAS  PubMed  Google Scholar 

  13. Wiley JL, Lefever TW, Cortes RA, Marusich LA (2014) Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats. Pharmacol Biochem Behav 124:123–128

    Article  CAS  PubMed  Google Scholar 

  14. Hermanns-Clausen M, Kneisel S, Szabo B, Auwärter V (2012) Acute toxicity due to confirmed consumption of synthetic cannabinoids: clinical and laboratory findings. Addiction 108:534–544

    Article  PubMed  Google Scholar 

  15. Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF (2011) Hijacking basic research: the case of synthetic cannabinoids. Methods Rep RTI Press (2011) 17971

  16. The United States Congress (2013) Protecting our youth from dangerous synthetic drugs Act of 2013. 113th Congress, 1st session introduced as Senate Bill 1323

  17. Nutt DJ, King LA, Nichols DE (2013) Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nature Rev Neurosci 14:577–585

    Article  CAS  Google Scholar 

  18. Wiley JL, Compton DR, Dai D, Lainton JAH, Phillips M, Huffman JW, Martin BR (1998) Structure–activity relationship of indole- and pyrrole-derived cannabinoids. J Pharmacol Exp Ther 285:995–1004

    CAS  PubMed  Google Scholar 

  19. Makriyannis A, Deng H (2001) Cannabimemetic indole derivatives. International Patent WO 01(28557):A1

    Google Scholar 

  20. Huffman JW, Mabon R, Wu M-J, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR (2003) 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor. Bioorg Med Chem 11:539–549

    Article  CAS  PubMed  Google Scholar 

  21. Huffman JW, Zengin G, Wu M-J, Lu J, Hynd G, Bushell K, Thompson ALS, Bushell S, Tartal C, Hurst DP, Reggio PH, Selley DE, Cassidy MP, Wiley JL, Martin BR (2005) Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptors agonists. Bioorg Med Chem 13(1):89–112

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors appreciate the thoughtful and critical critiques provided by Dr. Gregg Potter and Dr. Eric Nybo.

Conflict of interest

There are no financial or other relations that could lead to a conflict of interest.

Author information

Authors and Affiliations

  1. Ohio Attorney General’s Bureau of Criminal Investigation, London, OH, 43140, USA

    Travis J. Worst

  2. Department of Pharmaceutical Sciences, The College of Pharmacy, Ferris State University, Big Rapids, MI, 49307, USA

    Jon E. Sprague

Authors
  1. Travis J. Worst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon E. Sprague
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Travis J. Worst.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Worst, T.J., Sprague, J.E. The “pharmacophore rule” and the “spices”. Forensic Toxicol 33, 170–173 (2015). https://doi.org/10.1007/s11419-014-0243-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11419-014-0243-8

Keywords

Search

Navigation